The Latest Breaking News from Pfizer

Pfizer (PFE) is facing hurdles due to weakened demand for its products and pipeline diversification challenges. Nevertheless, the company exhibits long-term potential through strategic acquisitions. Given this scenario, what course of action should be considered ahead of the upcoming earnings release? Read more to find out.

According to reports, there have been 25 cases of accidental administration of Pfizer (Abrsyvo) or GSK (Arexvy) RSV vaccines to children below two and 128 cases of mistaken administration of the GSK RSV vaccine (Arexvy) to pregnant women.

A former Pfizer employee profited to the tune of $270,000 in an insider-trading scheme tied to Covid antiviral test results.

Five pharma companies will have sales that exceed $50 billion this year.

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

Artificial intelligence, electrification, hydrogen power, sustainability, human security, and mobility dominated the show floor.

Opponents of diversity programs are increasingly banking on an 1866 civil rights law meant to protect Black people from economic exclusion as a way to challenge corporate diversity and equity policies as well as funding to Black-owned businesses

Conservative advocates have filed a growing number of legal challenges, encouraged by the Supreme Court’s June ruling ending affirmative action in college admissions

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.

It comes as the ACT plans to stop recording COVID numbers.

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.